Home / Private raises / Pelthos Therapeutics Inc.

Pelthos Therapeutics Inc.

Pharmaceuticals · Durham, North Carolina · $57.5M sold across 1 offering

Form D filings (1)

FiledFormSoldOfferedInvestorsExemptionSecuritiesFirst sale
2026-11-16D (new)$57.5M$57.5M7506(b)Equity, Options/warrants, Security to be acquiredOct 30SEC ↗

An update (D/A) restates the running total of its offering, so the total above counts each offering's latest figure once.

Issuer

IndustryPharmaceuticals
LocatedDurham, North Carolina
EntityCorporation
IncorporatedNevada
SEC CIK1919246

People named in the latest filing

NameRole
Scott PleshaChief Executive Officer
John M. GayChief Financial Officer, Treasurer and Secretary
Sai RangaraoChief Commercial Officer
Richard BaxterDirector
Peter GreenleafChairman
Ezra FriedbergDirector
Todd DavisDirector
Richard MalamutDirector
Matthew PaulsDirector
Andrew EinhornDirector

Names and roles as filed with the SEC. Addresses are not shown.

Source: SEC EDGAR Form D filings. Amounts are self-reported by the issuer. Not investment advice.

How are we doing?